SSKN · As filed with the SEC
STRATA Skin Sciences income statement, by fiscal year
The statement as STRATA Skin Sciences presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| Revenues, net | 30,696 | 33,562 | 33,358 | 36,161 |
| Cost of revenues | 12,815 | 14,481 | 14,897 | 14,393 |
| Gross profit | 17,881 | 19,081 | 18,461 | 21,768 |
| Operating expenses: | ||||
| Engineering and product development | 421 | 883 | 1,317 | 1,029 |
| Selling and marketing | 13,111 | 12,289 | 12,956 | 15,301 |
| General and administrative | 10,184 | 11,303 | 10,508 | 10,087 |
| Impairment of goodwill | 0 | 3,861 | 2,284 | — |
| Settlement gains | (1,135) | — | — | — |
| Total operating expenses | 22,581 | 28,336 | 27,065 | 26,417 |
| Loss from operations | (4,700) | (9,255) | (8,604) | (4,649) |
| Interest expense | — | — | (1,640,000) | (926,000) |
| Interest expense | (1,959) | (2,107) | — | — |
| Interest income | 410 | 242 | 231 | 89 |
| Gain on forgiveness of debt | — | — | — | 0 |
| Loss on debt extinguishment | — | 0 | (909,000) | — |
| Other income | 0 | 864 | — | — |
| Other (expense), income net | (1,549) | (1,001) | (2,318) | (837) |
| Loss before (provision for) benefit from income taxes | (6,249) | (10,256) | (10,922) | (5,486) |
| (Provision for) benefit from income taxes | (12) | 170 | 92 | (63) |
| Net loss | (6,261) | (10,086) | (10,830) | (5,549) |
| Net loss per share of common stock - basic (in Dollars per share) | (1.35) | (2.65) | (0.31) | — |
| Common Shares | — | — | — | (0.16) |
| Net loss per share of common stock - diluted (in Dollars per share) | (1.35) | (2.65) | (0.31) | — |
| Common Shares | — | — | — | (0.16) |
| Weighted average shares of common stock outstanding - basic (in Shares) | 4,650,556 | 3,807,186 | 34,920,291 | — |
| Common Shares | — | — | — | 34,712,246 |
| Weighted average shares of common stock outstanding - diluted (in Shares) | 4,650,556 | 3,807,186 | 34,920,291 | — |
| Common Shares | — | — | — | 34,712,246 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.